Advertisement
UK markets open in 2 hours 56 minutes
  • NIKKEI 225

    37,941.99
    +313.51 (+0.83%)
     
  • HANG SENG

    17,593.66
    +309.12 (+1.79%)
     
  • CRUDE OIL

    83.82
    +0.25 (+0.30%)
     
  • GOLD FUTURES

    2,346.20
    +3.70 (+0.16%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,481.88
    +16.56 (+0.03%)
     
  • CMC Crypto 200

    1,390.06
    +7.48 (+0.54%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

What Analysts Recommend for Gilead Sciences in April 2018

What Analysts Recommend for Gilead Sciences in April 2018

In 4Q17, Gilead Sciences (GILD) reported revenues close to $5.9 billion, which is a year-over-year (or YoY) drop of around 19%. Gilead Sciences reported net product sales close to $5.8 billion in 4Q17, which is a YoY decline of 19% and a quarter-over-quarter drop close to 9%. The company also reported net product sales close to $25.7 billion for fiscal 2017, which is a YoY decline of around 14%.